Clinical Trial Update: Phase 1 Study of Terameprocol (EM-1421) in Patients With Leukemia [Phase 1]

View source ↗

Summary

Phase 1 study of Terameprocol (EM-1421) in leukemia was terminated; no efficacy results were reported in this update.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia
• Chronic Lymphocytic Leukemia
• Chronic Myeloid Leukemia
• Leukemia
• Myelodysplastic Syndrome
• Myelomonocytic Leukemia
• T-cell Leukemia

Drugs mentioned

• Terameprocol (terameprocol)

Snippet

Sponsor: Erimos Pharmaceuticals | Conditions: Leukemias, Acute Myeloid Leukemia (AML) | Phase 1 | Status: TERMINATED